• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在采用氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)引导的颈部处理策略后,N3(>6 cm)头颈部鳞状细胞癌患者接受原发性放化疗后的结果。

Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.

作者信息

Adams Gerard, Porceddu Sandro V, Pryor David I, Panizza Benedict, Foote Matthew, Rowan Ann, Burmeister Bryan

机构信息

Princess Alexandra Hospital, Head and Neck Radiation Oncology Cancer Service, Brisbane, Queensland, Australia; University of Queensland, St. Lucia, Queensland, Australia.

出版信息

Head Neck. 2014 Aug;36(8):1200-6. doi: 10.1002/hed.23434. Epub 2013 Oct 19.

DOI:10.1002/hed.23434
PMID:23893554
Abstract

BACKGROUND

The purpose of this study was to assess whether a positron emission tomography (PET)-directed policy remains appropriate for managing neck nodes (N3; >6 cm) in head and neck squamous cell carcinoma (HNSCC).

METHODS

All patients with N3 (>6 cm) HNSCC treated with definitive chemoradiotherapy (CRT) at our institution between 2005 and 2012 were included in the analysis. Patients underwent PET assessment before and 12 weeks after CRT. Neck dissections were performed for PET-avid residual nodal abnormalities after complete response at the primary site. Rate of isolated nodal failure (INF) was the primary outcome.

RESULTS

Median follow-up from diagnosis for 33 patients was 30 months (range, 6-76 months). INF occurred in 2 patients (6%) with neck dissections performed in 4 cases (12%). First failure was predominantly distant metastatic (10; 30%).

CONCLUSION

The rate of INF remains low when following a PET-directed neck management policy after definitive CRT for N3 (>6 cm) HNSCC.

摘要

背景

本研究旨在评估正电子发射断层扫描(PET)引导策略对于头颈部鳞状细胞癌(HNSCC)颈部淋巴结(N3;直径>6 cm)管理是否仍然适用。

方法

纳入2005年至2012年间在本机构接受根治性放化疗(CRT)的所有N3(直径>6 cm)HNSCC患者进行分析。患者在CRT前及CRT后12周接受PET评估。对原发部位达到完全缓解后PET显示有残留淋巴结异常的患者进行颈部清扫术。孤立性淋巴结失败(INF)率是主要观察指标。

结果

33例患者从诊断开始的中位随访时间为30个月(范围6 - 76个月)。2例患者发生INF(6%),4例患者进行了颈部清扫术(12%)。首次失败主要为远处转移(10例;30%)。

结论

对于N3(直径>6 cm)HNSCC患者,在根治性CRT后采用PET引导的颈部管理策略时,INF发生率仍然较低。

相似文献

1
Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.在采用氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)引导的颈部处理策略后,N3(>6 cm)头颈部鳞状细胞癌患者接受原发性放化疗后的结果。
Head Neck. 2014 Aug;36(8):1200-6. doi: 10.1002/hed.23434. Epub 2013 Oct 19.
2
Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.器官保留治疗后,正电子发射断层扫描引导下颈部处理在淋巴结阳性头颈癌中的长期结果。
Oral Oncol. 2015 Mar;51(3):260-6. doi: 10.1016/j.oraloncology.2014.12.009. Epub 2014 Dec 29.
3
Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.头颈部鳞状细胞癌的治疗反应评估与患者预后:FDG PET霍普金斯标准与残留颈部淋巴结大小及形态特征
AJR Am J Roentgenol. 2016 Sep;207(3):641-7. doi: 10.2214/AJR.15.15730. Epub 2016 Jun 24.
4
The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.CT和¹⁸F-FDG PET在放化疗后颈部淋巴结阳性的头颈癌治疗中的作用。
Acta Otolaryngol. 2009 Aug;129(8):893-9. doi: 10.1080/00016480802441747.
5
The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.18F-FDG PET-CT最大标准化摄取值变化在接受放化疗的头颈部鳞状细胞癌患者治疗后监测中的作用:初步研究结果
Br J Radiol. 2017 Mar;90(1071):20150404. doi: 10.1259/bjr.20150404. Epub 2017 Jan 5.
6
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.头颈部鳞状细胞癌初始放化疗后行 FDG-PET 引导颈部管理的经济学分析。
Head Neck. 2013 Sep;35(9):1287-94. doi: 10.1002/hed.23108. Epub 2012 Sep 18.
7
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中采用延迟(18)F-FDG PET-CT反应评估的结局评估
Br J Radiol. 2015 Aug;88(1052):20140592. doi: 10.1259/bjr.20140592. Epub 2015 Jun 17.
8
Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.在 N2 头颈部鳞状细胞癌中,序贯放化疗后及治疗后阴性正电子发射断层扫描/计算机断层扫描(PET-CT)可避免颈清扫术。
Clin Oncol (R Coll Radiol). 2011 Oct;23(8):512-7. doi: 10.1016/j.clon.2011.03.008. Epub 2011 Apr 17.
9
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.PET-NECK:一项多中心随机III期非劣效性试验,比较正电子发射断层扫描-计算机断层扫描引导下的观察等待策略与计划性颈部清扫术在治疗头颈部鳞状细胞癌局部晚期(N2/N3)淋巴结转移中的效果。
Health Technol Assess. 2017 Apr;21(17):1-122. doi: 10.3310/hta21170.
10
The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.正电子发射断层扫描在头颈部鳞状细胞癌放化疗后N阳性颈部管理中的作用。
Laryngoscope. 2006 Jun;116(6):855-8. doi: 10.1097/01.mlg.0000214668.98592.d6.

引用本文的文献

1
Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo)radiotherapy for their primary.对于患有晚期淋巴结疾病的头颈部鳞状细胞癌患者,在对其原发灶进行根治性(化疗)放疗时,颈部处理方面的进展及尚存的知识空白
Strahlenther Onkol. 2024 Jul;200(7):553-567. doi: 10.1007/s00066-024-02228-4. Epub 2024 Apr 10.
2
N3 (> 6 cm) squamous cell carcinoma of the head and neck: outcomes and predictive factors in 104 patients.头颈部 N3 (> 6 cm) 鳞状细胞癌:104 例患者的结果和预测因素。
Acta Otorhinolaryngol Ital. 2021 Jun;41(3):221-229. doi: 10.14639/0392-100X-N1437.
3
Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer.
对于 >6cm 淋巴结(N3)头颈部癌,双模态确定性放化疗的结果与三模态初始颈部清扫术加辅助治疗的结果没有区别。
PLoS One. 2019 Dec 3;14(12):e0225962. doi: 10.1371/journal.pone.0225962. eCollection 2019.
4
Neck management in head and neck squamous cell carcinomas: where do we stand?头颈部鳞状细胞癌的颈部管理:我们处于什么位置?
Med Oncol. 2019 Mar 27;36(5):40. doi: 10.1007/s12032-019-1265-1.
5
Feasibility of rapid integrated radiation therapy planning with follow-up FDG PET/CT to improve overall treatment assessment in head and neck cancer.采用后续FDG PET/CT进行快速综合放射治疗计划以改善头颈癌整体治疗评估的可行性。
Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):24-29. eCollection 2019.
6
Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With p16/HPV-Positive Oropharyngeal Cancer.p16/HPV 阳性口咽癌患者治疗后 18F-FDG PET/CT 阴性的意义。
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1029-1035. doi: 10.1016/j.ijrobp.2018.06.031. Epub 2018 Jun 28.
7
(18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.(18)采用氟代脱氧葡萄糖(¹⁸F-FDG)PET/CT评估口咽鳞状细胞癌放化疗后的反应并指导风险分层随访。
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1239-47. doi: 10.1007/s00259-015-3290-4. Epub 2015 Dec 28.
8
Less may be more: nodal treatment in neck positive head neck cancer patients.少或许就是多:颈部淋巴结阳性头颈癌患者的淋巴结治疗
Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1549-56. doi: 10.1007/s00405-015-3634-5. Epub 2015 Apr 29.